Saratoga Investment Corp SAY Q1 2026 Earnings Significant EPS Miss Despite Slight Stock Uptick PD Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick Immunome Inc IMNM Q1 2026 Earnings Narrower Loss Beats Estimates Stock Gains Modestly MSDL Q1 2026 Earnings Modest EPS Beat amid Flat Revenue Profile Traws Pharma Q1 2026 Earnings Narrowed Loss Surpasses Expectations Amid PreRevenue Stage MT Q1 2026 Earnings Modest EPS Beat Amid Revenue Uncertainty